USGovernment-News.Com

USGovernment-News.Com

News on U.S. government agencies, U.S. politics, companies doing business with U.S. federal government. Read U.S. national and local news. This site is not affiliated with United States Government.
Press release distribution service
Home : U.S. Government News Search Engine                          

Home > U.S. Government News > Marketplace :
Home: United State Government News
Home | News | Submit Press Release |

ClassAction.org Warns Consumers of Link Between Zocor 80mg and Rhabdomyolysis, a Serious Muscle Condition

(EMAILWIRE.COM, June 30, 2010 ) New York, NY - ClassAction.org is currently investigating claims on behalf of patients who have been diagnosed with rhabdomyolysis after taking any of the following medications: Zocor (80mg), Vytorin 10/80, or the generic simvastatin (80mg). Rhabdomyolysis is a life-threatening muscle condition, which can lead to kidney damage, kidney failure, and death. In March 2010, the Food & Drug Administration (FDA) announced that Zocor (80mg) can put patients at risk for this potentially dangerous condition. Since that time, ClassAction.org has been providing legal help and information information to patients with Zocor rhabdomyolysis claims.

Zocor is a medication that lowers cholesterol by blocking the production of cholesterol in the body. Zocor is manufactured by Merck. The recent FDA warning reported that patients taking 80mg doses of Zocor have a risk of developing rhabdomyolysis that is fifty times greater than those taking the 20mg dose. In addition, the FDA stated that patients taking Vytorin 10/80 (a combination drug that contains Zocor) and the generic drug simvastatin (80mg) are also at risk for this Zocor side effect.

Rhabdomyolysis is a severe form of muscle damage that is characterized by the rapid destruction of skeletal muscle. This can result in the release of muscle fiber contents into the bloodstream, which can lead to kidney damage, kidney failure, and death. Symptoms of rhabdomyolysis include the following: muscle aches and pains, muscle weakness, stiffness and tenderness of muscles, and darkening of urine.

If you have taken Zocor (80mg), Vytorin 10/80 or simvastatin (80mg) and your doctor has diagnosed you with rhabdomyolysis, you may be eligible to participate in a Zocor rhabdomyolysis lawsuit. ClassAction.org is currently offering a Free Case Evaluation for patients who have been diagnosed with rhabdomyolysis after taking any of these medications. A Zocor attorney can advise you of your legal rights and determine if you are entitled to financial compensation for medical expenses, lost wages, or any other types of damages.

About ClassAction.org

ClassAction.org is dedicated to protecting consumers and investors in class actions and complex litigation throughout the United States. ClassAction.org keeps consumers informed about product alerts, recalls, and emerging litigation and helps them take action against the manufacturers of defective products, drugs, and medical devices. Information about consumer fraud issues and environmental hazards is also available on the site. Visit http://www.classaction.org today for a no cost, no obligation case evaluation and information about your consumer rights.


ClassAction.org
Liz Ryan
800-449-1970
pressrelease@lawyercentral.com

Source: EmailWire.com

U.S. Governement News: Politics
  • Presidential Elections
  • Democrates
  • Congress
  • House of Representatives
  • President Obama
  • Republican Party
  • Mitt Romney
  • U.S. Senate
  • U.S. Military
  • U.S. Politics
  • Politics Video Feeds

    U.S. Government Resource Center
    We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Industry resource center today to browse our selection of 600+ complimentary Industry magazines, white papers, webinars, podcasts, and more. Get popular titles including:

    Governing
    Point of Beginning
    Overall Labor Effectiveness (OLE) Achieving a Highly Effective Workforce

    No credit cards, coupons, or promo codes required. Try it today!

    USGovernment-News.Com is a news service of GroupWeb Media LLC